JP2022528915A5 - - Google Patents

Info

Publication number
JP2022528915A5
JP2022528915A5 JP2021559659A JP2021559659A JP2022528915A5 JP 2022528915 A5 JP2022528915 A5 JP 2022528915A5 JP 2021559659 A JP2021559659 A JP 2021559659A JP 2021559659 A JP2021559659 A JP 2021559659A JP 2022528915 A5 JP2022528915 A5 JP 2022528915A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
alkenyl
epoxy
hexahydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021559659A
Other languages
English (en)
Japanese (ja)
Other versions
JP7900152B2 (ja
JP2022528915A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2020/050360 external-priority patent/WO2020206504A1/en
Publication of JP2022528915A publication Critical patent/JP2022528915A/ja
Publication of JP2022528915A5 publication Critical patent/JP2022528915A5/ja
Priority to JP2024231893A priority Critical patent/JP2025060945A/ja
Application granted granted Critical
Publication of JP7900152B2 publication Critical patent/JP7900152B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021559659A 2019-04-12 2020-04-09 腫瘍を治療することの方法 Active JP7900152B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024231893A JP2025060945A (ja) 2019-04-12 2024-12-27 腫瘍を治療することの方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2019901280A AU2019901280A0 (en) 2019-04-12 Method of Treatment
AU2019901280 2019-04-12
PCT/AU2020/050360 WO2020206504A1 (en) 2019-04-12 2020-04-09 Method of treating tumours

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024231893A Division JP2025060945A (ja) 2019-04-12 2024-12-27 腫瘍を治療することの方法

Publications (3)

Publication Number Publication Date
JP2022528915A JP2022528915A (ja) 2022-06-16
JP2022528915A5 true JP2022528915A5 (cg-RX-API-DMAC7.html) 2023-01-26
JP7900152B2 JP7900152B2 (ja) 2026-08-04

Family

ID=72752169

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021559659A Active JP7900152B2 (ja) 2019-04-12 2020-04-09 腫瘍を治療することの方法
JP2024231893A Withdrawn JP2025060945A (ja) 2019-04-12 2024-12-27 腫瘍を治療することの方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024231893A Withdrawn JP2025060945A (ja) 2019-04-12 2024-12-27 腫瘍を治療することの方法

Country Status (26)

Country Link
US (1) US12226391B2 (cg-RX-API-DMAC7.html)
EP (1) EP3952858B1 (cg-RX-API-DMAC7.html)
JP (2) JP7900152B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210152531A (cg-RX-API-DMAC7.html)
CN (1) CN113924091A (cg-RX-API-DMAC7.html)
AU (1) AU2020256847B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021020253A2 (cg-RX-API-DMAC7.html)
CA (1) CA3136216C (cg-RX-API-DMAC7.html)
DK (1) DK3952858T3 (cg-RX-API-DMAC7.html)
EA (1) EA202192757A1 (cg-RX-API-DMAC7.html)
ES (1) ES3063750T3 (cg-RX-API-DMAC7.html)
FI (1) FI3952858T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20260232T1 (cg-RX-API-DMAC7.html)
IL (1) IL287210B2 (cg-RX-API-DMAC7.html)
LT (1) LT3952858T (cg-RX-API-DMAC7.html)
MX (1) MX2021012449A (cg-RX-API-DMAC7.html)
MY (1) MY208979A (cg-RX-API-DMAC7.html)
PL (1) PL3952858T3 (cg-RX-API-DMAC7.html)
PT (1) PT3952858T (cg-RX-API-DMAC7.html)
RS (1) RS67777B1 (cg-RX-API-DMAC7.html)
SG (1) SG11202110599RA (cg-RX-API-DMAC7.html)
SI (1) SI3952858T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202600066T1 (cg-RX-API-DMAC7.html)
UA (1) UA129840C2 (cg-RX-API-DMAC7.html)
WO (1) WO2020206504A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202108677B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1971588T3 (da) * 2005-12-23 2012-10-22 Qbiotics Ltd Tiglien-3-onderivater
JP7013753B2 (ja) * 2017-09-15 2022-02-01 株式会社三洋物産 遊技機
BR112021024716A2 (pt) 2019-06-19 2022-02-08 QBiotics Pty Ltd Ruptura de biofilme
CN118451065A (zh) * 2021-12-21 2024-08-06 Q生物股份有限公司 结晶中间体
EP4638430A4 (en) * 2022-12-21 2026-07-01 QBiotics Pty Ltd CRYSTALLINE FORMS AND THEIR PRODUCTION PROCESSES

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1971588T3 (da) * 2005-12-23 2012-10-22 Qbiotics Ltd Tiglien-3-onderivater
PT2986615T (pt) 2013-04-18 2019-03-22 Qbiotics Ltd Métodos e composições para a cicatrização de feridas
EP3490547A4 (en) * 2016-07-28 2020-04-01 QBiotics Pty Ltd TREATMENT METHOD
SG11201907891XA (en) * 2017-03-23 2019-09-27 QBiotics Pty Ltd Combination therapy for the treatment or prevention of tumours

Similar Documents

Publication Publication Date Title
JP2022121594A5 (cg-RX-API-DMAC7.html)
JP2020511512A5 (cg-RX-API-DMAC7.html)
JP2021522193A5 (cg-RX-API-DMAC7.html)
JP2010532768A5 (cg-RX-API-DMAC7.html)
JP2021523159A5 (cg-RX-API-DMAC7.html)
JP2018517686A5 (cg-RX-API-DMAC7.html)
EA003877B1 (ru) Ингибиторы фарнезилпротеинтрансферазы, обладающие in vivo радиосенсибилизирующими свойствами
JP2006523216A5 (cg-RX-API-DMAC7.html)
JP2018504418A5 (cg-RX-API-DMAC7.html)
JP2010540556A5 (cg-RX-API-DMAC7.html)
JP2023101521A5 (cg-RX-API-DMAC7.html)
JP2018536636A5 (cg-RX-API-DMAC7.html)
JP2018534288A5 (cg-RX-API-DMAC7.html)
JP2010540555A5 (cg-RX-API-DMAC7.html)
JP2021530487A5 (cg-RX-API-DMAC7.html)
JP2021530444A5 (cg-RX-API-DMAC7.html)
JP2008506710A5 (cg-RX-API-DMAC7.html)
JP2015536997A5 (cg-RX-API-DMAC7.html)
JP2022528915A (ja) 腫瘍を治療することの方法
JP2012522841A5 (cg-RX-API-DMAC7.html)
JP2023548190A5 (cg-RX-API-DMAC7.html)
JP2014523413A5 (cg-RX-API-DMAC7.html)
CO2024002712A2 (es) Azálidos inmunomoduladores
JP2009502777A5 (cg-RX-API-DMAC7.html)
JP2021511344A5 (cg-RX-API-DMAC7.html)